Inici > Esdeveniments & Notícies > Barcelona Global Update > FreeOx Biotech, a spin-out of Hospital Clinic Barcelona-IDIBAPS, has closed its first funding round with €500,000 for development and creation of new drugs to prevent strokes.
FreeOx Biotech, a spin-out of Hospital Clinic Barcelona-IDIBAPS, has closed its first funding round with €500,000 for development and creation of new drugs to prevent strokes.
